wedelolactone and Uterine-Cervical-Neoplasms

wedelolactone has been researched along with Uterine-Cervical-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for wedelolactone and Uterine-Cervical-Neoplasms

ArticleYear
Trimodal synergistic antitumor drug delivery system based on graphene oxide.
    Nanomedicine : nanotechnology, biology, and medicine, 2019, Volume: 15, Issue:1

    A multifunctional antitumor drug delivery system was synthesized based on graphene oxide (GO) for near-infrared (NIR) light controlling chemotherapeutic/photothermal (PTT) /photodynamic (PDT) trimodal synergistic therapy. The system named ICG-Wed-GO was formed by co-loading wedelolactone (Wed) and indocyanine green (ICG) on the surface of GO through π-π stacking interaction. Under NIR laser irradiation, ICG-Wed-GO could effectively absorb and transform optical energy to heat, generate reactive oxygen species (ROS) to ablating and damage tumor cells. The temperature of ICG-Wed-GO solution reached up to 79.4 °C in 10 min with NIR irradiation. In in vitro and in vivo study, ICG-Wed-GO showed excellent antitumor effect. After 14-day treatment of ICG-Wed-GO with NIR laser irradiation, the tumor disappeared completely on tumor-bearing mice. The low biotoxicity of ICG-Wed-GO was also proved. The system achieved the synergistic trimodal chemotherapeutic/photothermal/photodynamic treatment and demonstrated excellent antitumor effect, which is expected to have a greater potential for cancer therapy.

    Topics: Animals; Coloring Agents; Coumarins; Drug Delivery Systems; Female; Graphite; Hyperthermia, Induced; Indocyanine Green; Mice; Photochemotherapy; Reactive Oxygen Species; Tumor Cells, Cultured; Uterine Cervical Neoplasms

2019